Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed the day trading at $0.75 down -6.34% from the previous closing price of $0.81. In other words, the price has decreased by -$6.34 from its previous closing price. On the day, 1.68 million shares were traded. CTXR stock price reached its highest trading level at $0.8236 during the session, while it also had its lowest trading level at $0.7244.
Ratios:
For a better understanding of CTXR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.06 and its Current Ratio is at 5.06. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 30, 2021, initiated with a Buy rating and assigned the stock a target price of $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTXR now has a Market Capitalization of 120021280 and an Enterprise Value of 100704432.
Stock Price History:
Over the past 52 weeks, CTXR has reached a high of $1.65, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -4.09%, while the 200-Day Moving Average is calculated to be -7.64%.
Shares Statistics:
Over the past 3-months, CTXR traded about 830.26K shares per day on average, while over the past 10 days, CTXR traded about 1386990 shares per day. A total of 158.86M shares are outstanding, with a floating share count of 146.79M. Insiders hold about 7.74% of the company’s shares, while institutions hold 16.95% stake in the company. Shares short for CTXR as of 1711584000 were 12425469 with a Short Ratio of 14.97, compared to 1709164800 on 11863452. Therefore, it implies a Short% of Shares Outstanding of 12425469 and a Short% of Float of 8.469999999999999.
Earnings Estimates
A detailed examination of Citius Pharmaceuticals Inc (CTXR) is currently in progress, with Citius Pharmaceuticals, Inc. analysts providing valuable insights into its market dynamics.
